CM Management’s Bristol-Myers Squibb BMY Stock Holding History

CM Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,000	Closed	-$935K	–	74
2021 Q4	$935K	Buy	+15,000	New	+$880K	0.71%	49
2021 Q3	–	Sell	-20,000	Closed	-$1.34M	–	93
2021 Q2	$1.34M	Hold	20,000	–	–	0.97%	38
2021 Q1	$1.26M	Buy	+20,000	New	+$1.24M	0.94%	40

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

CM Management's BMY Position: Q1 2022 in Review

CM Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 15,000 shares — an estimated $935K sold.

CM Management first reported a position in BMY in Q1 2021 and held it in 3 quarters. The position peaked at $1.34M in Q2 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

CM Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
CM Management sold 15,000 Bristol-Myers Squibb shares in Q1 2022, an estimated $935K.
CM Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 3 quarters.
CM Management's Bristol-Myers Squibb position peaked at $1.34M in Q2 2021.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on CM Management's 13F filing for Q1 2022, filed 9 May 2022.